Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (361-370 of 412) with videos related to

Pageof 42
Sort By:
Autoimmunity Reviews|January 4, 2015
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive casesJaume Alijotas-Reig, Raquel Ferrer-Oliveras, Amelia Ruffatti, et al.
Annals of the Rheumatic Diseases|November 22, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndromeMaria G Tektonidou, Ricard Cervera, Angela Tincani, et al.
Arthritis Care & Research|September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and RepositoryEcem Sevim, Diane Zisa, Danieli Andrade, et al.
Autoimmunity Reviews|July 10, 2012
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritisLaurent Arnaud, Hervé Devilliers, Stanford L Peng, et al.
Lupus|July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION RegistryStéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Rheumatology (Oxford, England)|October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.
Clinical Pharmacology and Therapeutics|August 7, 2018
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Arthritis and Rheumatism|April 16, 2002
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsRicard Cervera, Jean-Charles Piette, Josep Font, et al.
Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Pageof 42

Showing results (361-370 of 412) with videos related to

Sort By:
Pageof 42
Autoimmunity Reviews|January 4, 2015
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive casesJaume Alijotas-Reig, Raquel Ferrer-Oliveras, Amelia Ruffatti, et al.
Annals of the Rheumatic Diseases|November 22, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndromeMaria G Tektonidou, Ricard Cervera, Angela Tincani, et al.
Arthritis Care & Research|September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and RepositoryEcem Sevim, Diane Zisa, Danieli Andrade, et al.
Autoimmunity Reviews|July 10, 2012
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritisLaurent Arnaud, Hervé Devilliers, Stanford L Peng, et al.
Lupus|July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION RegistryStéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Rheumatology (Oxford, England)|October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.
Clinical Pharmacology and Therapeutics|August 7, 2018
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Arthritis and Rheumatism|April 16, 2002
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patientsRicard Cervera, Jean-Charles Piette, Josep Font, et al.
Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.
Pageof 42